Genor Biopharma Revenue and Competitors
Estimated Revenue & Valuation
- Genor Biopharma's estimated annual revenue is currently $12.7M per year.
- Genor Biopharma's estimated revenue per employee is $155,000
Employee Data
- Genor Biopharma has 82 Employees.
- Genor Biopharma grew their employee count by -2% last year.
Genor Biopharma's People
Name | Title | Email/Phone |
---|---|---|
1 | Senior Director-Head Clinical Operations | Reveal Email/Phone |
Genor Biopharma Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Genor Biopharma?
Genor Biopharma Co. Ltd is a biopharmaceutical powerhouse focusing on developing and commercializing oncology and autoimmune drugs. We have successfully developed drug candidates targeting pathways with blockbuster potentials, encompassing top three oncology targets and five out of the ten bestselling drugs globally. We have leveraged primarily in-house capabilities in establishing a pipeline of 15 targeted drug candidates with tremendous commercialization potentials in China that cover both proven and novel biological pathways.
keywords:N/AN/A
Total Funding
82
Number of Employees
$12.7M
Revenue (est)
-2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Genor Biopharma News
Biocon Limited, Epirus Biopharmaceuticals, Genor BioPharma Co. Ltd., Hetero Drugs Limited, Mabion SA, Mycenax Biotech Inc., Oncobiologics, Oncodesign SA,...
... Boehringer Ingelheim, CytomX Therapeutics, Beta Pharma (Suzhou) Co., ... Inc., Kind Pharmaceuticals LLC, Genor Biopharma Co., Ltd.,...
Amgen, AryoGen Biopharma, Biocon, Celltrion, Gedeon Richter, Genor Biopharma, Mabion, Mylan, Roche, The Instituto Vital Brazil.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $12M | 83 | 6% | N/A |
#2 | $12.2M | 84 | -1% | N/A |
#3 | $12.2M | 84 | 6% | N/A |
#4 | $9.2M | 88 | N/A | N/A |
#5 | $18.3M | 91 | 6% | N/A |